However, we extend these findings further by presenting results from breast cancer patient samples, as well as in vivo data generated from limiting dilution assays in mice that revealed a dramatic decrease in tumor-initiating capacity, when LSD1 was inhibited or knocked-down, respectively. Here, KDM1A is linked to neoplasm.